duloxetine hydrochloride has been researched along with Autism Spectrum Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Joseph, TP; Lin, SL; Sai, LY; Schachner, M; Zhou, F | 1 |
| Mannekote Thippaiah, S; Nanjappa, MS; Pradhan, B; Voyiaziakis, E | 1 |
1 review(s) available for duloxetine hydrochloride and Autism Spectrum Disorder
| Article | Year |
|---|---|
Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review.
Topics: Adult; Antidepressive Agents; Autism Spectrum Disorder; Child; Duloxetine Hydrochloride; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors | 2022 |
1 other study(ies) available for duloxetine hydrochloride and Autism Spectrum Disorder
| Article | Year |
|---|---|
Duloxetine ameliorates valproic acid-induced hyperactivity, anxiety-like behavior, and social interaction deficits in zebrafish.
Topics: Animals; Anxiety; Autism Spectrum Disorder; Behavior, Animal; Disease Models, Animal; Duloxetine Hydrochloride; Prenatal Exposure Delayed Effects; Social Behavior; Social Interaction; Valproic Acid; Zebrafish | 2022 |